# ImprimisRx CA, Inc., dba ImprimisRx – FDA Inspection, Mar 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/imprimisrx-ca-inc-dba-imprimisrx/0348a645-ed8b-41d9-8562-d9264b8c7e7d
Source feed: FDA_Inspections

> FDA inspection 1010017 of ImprimisRx CA, Inc., dba ImprimisRx, March 31, 2017. 3 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010017
- Company Name: ImprimisRx CA, Inc., dba ImprimisRx
- Inspection Date: 2017-03-31
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 962695 - 2016-03-14](https://www.keypedia.com/records/fda_inspections/imprimisrx-ca-inc-dba-imprimisrx/9b577143-3469-4f01-8b62-07a123ec609a)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Theresa Kirkham](https://www.keypedia.com/people/theresa-kirkham/c7d8aad0-d162-4fac-a1ba-4649c36fd714)

Company: https://www.keypedia.com/companies/imprimisrx-ca-inc-dba-imprimisrx/4fe86729-76bc-40f3-ba28-530af52598c6

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b